Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Qixleef not any money for years !

<< Previous

Bullboard Posts

Next >>

Comment by Craiger02on Jan 04, 2022 7:48pm

240 Views

Post# 34283613

RE:RE:RE:RE:RE:RE:Qixleef not any money for years !

The way it looks right now, we will know within the next 2-6 months. The last raise was a disaster and is showing that institutional investment interest has wained drastically. Time to sink or swim as they will be out of money very soon without very good SOLID news. I can't see Guy delivering anything good in that timeframe. Hope I'm wrong but just can't see it. He has no business sense at all and has completely failed to be even somewhat transparent. We stood a chance at success had he appointed a proper CEO a year ago.

SamV21 wrote: SAINT LAURENT, Quebec, Dec. 08, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has initiated an arbitration proceeding against Tilray, Inc. (“Tilray®”) related to an alleged breach of the parties’ 2018 license, development and supply agreement, as amended (the “Agreement”), with Tilray® for the co-development and commercialization of cannabis-infused VersaFilm® products.
This is the company that Tetra gave undisclosed amounts to and partnered up with for the Dronabinol strips for Tetra in 2018 , another gold fish in the shark tank.
So like tetra to connect itself with another company worth 60,000,000 and try to take on the big boys.If there is a buy out it will be 100 Tetra to 1 Tilray because once a company is broke it has no choice either shut down or take the deal.The question to shareholders will be do you want something or nothing for the shares you hold ? I have seen it before Aurora bought Hempco at 33 hempco shares to one Aurora,shareholders had no choice , then Aurora consolidated 12 shares to 1 to keep the price up above a dollar in 2020. And that is what is coming soon as far as big news in 2022 for Tetra with no product and no revenue for years.Where is the CEO ?? Zero for updates or even comments on what is really happening, this item does effect Tetra where is GUY hidding ?.Just be honest for once and stop saying shareholders don't understand, NO he doesn't understand the useless milestones they brag about.Just keep pumping money so we can shuffle it around into other companies.No body trusts CEO Guy anymore he has made to many false promises of income and revenue soon since 2018 and his 10 week study going on 4 years now.